EP1948149
Samsetning sem inniheldur metformín og vildagliptín
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
25.9.2006EP published:
16.11.2011EP application number:
06815305.5
EP translation filed:
2.2.2012Grant published:
15.2.2012EPO information:
European Patent Register
Max expiry date:
24.9.2026Expiry date:
24.9.2023
Title:
FORMULATION COMPRISING METFORMIN AND VILDAGLIPTIN
Timeline
Today
25.9.2006EP application
16.11.2011EP Publication
2.2.2012Translation submitted
15.2.2012Registration published
24.9.2023Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
JOSHI, YatindraAddress:
Princeton, NJ, US
Name:
KOWALSKI, JamesAddress:
Belle Mead, NJ, US
Name:
LAKSHMAN, Jay, ParthibanAddress:
Cedar Knolls, NJ, US
Name:
ROYCE, Alan, EdwardAddress:
Saylorsburg, PA, US
Name:
TONG, Wei-QinAddress:
Basking Ridge, NJ, US
Name:
VASANTHAVADA, MadhavAddress:
Basking Ridge, NJ, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
722624 PDate:
29.9.2005Country:
US
Classification
Categories:
A61K 31/155, A61K 31/40, A61P 3/10, A61K 9/20, A61K 9/48, A61K 31/4439
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 14.8.2012
Expires: 24.9.2013
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 8.8.2013
Expires: 24.9.2014
Payer: Árnason Faktor
Number: 9
Paid: 6.8.2014
Expires: 24.9.2015
Payer: Árnason Faktor
Number: 10
Paid: 6.8.2015
Expires: 24.9.2016
Payer: Árnason Faktor
Number: 11
Paid: 8.8.2016
Expires: 24.9.2017
Payer: Árnason Faktor
Number: 12
Paid: 24.8.2017
Expires: 24.9.2018
Payer: Árnason Faktor
Number: 13
Paid: 23.8.2018
Expires: 24.9.2019
Payer: Árnason Faktor
Number: 14
Paid: 27.8.2019
Expires: 24.9.2020
Payer: Árnason Faktor
Number: 15
Paid: 25.8.2020
Expires: 24.9.2021
Payer: Árnason Faktor ehf.
Number: 16
Paid: 23.8.2021
Expires: 24.9.2022
Payer: Árnason Faktor ehf.
Number: 17
Paid: 30.8.2022
Expires: 24.9.2023
Payer: Árnason Faktor ehf.